Thank you, Nasdaq, for the incredible opportunity to ring the Opening Bell! It was an unforgettable moment to celebrate Septerna’s IPO thanks to our dedicated team, investors, and supporters. This milestone marks the beginning of an exciting new chapter as we work to unlock the potential of GPCR-targeted therapies and transform patient care. We’re proud to join the NASDAQ family as $SEPN! #Biotech #NASDAQListed
💫 Their mission: to pioneer a new era of G protein coupled receptors. 🔬 Septerna is unlocking the therapeutic potential of GPCRs to address unmet patient needs. 🔔 It’s an honor to celebrate with you as you join the #NasdaqListed family, $SEPN!